Navigation Links
ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy

HOUSTON--(BUSINESS WIRE)--Jun 7, 2007 - ApoCell, Inc. presented the results of a study conducted by researchers at the University of Chicago and ApoCell at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held in Chicago in early June. The study showed that ApoCell's advanced pharmacodynamic biomarker assay technology provides reliable predictive data of clinical response. This study showed the benefit of treating aggressive head and neck cancer patients with a combination of targeted molecular drugs.

Cancer treatment is evolving from the use of highly toxic systemic compounds to targeted molecular drugs that are safer and faster acting because they aim only at cancer cell structures and their bio-mechanisms. Pharmacodynamics is an evolving field that encompasses the study of the biochemical and physiological effects of drugs, the mechanisms of drug action and the relationship between drug concentration and biological effect.

ApoCell has developed an analytical tool, the PDx Index(TM) (Pharmaco-Diagnostic Index), which indicates the likelihood of whether a targeted therapy will elicit a clinical response. The predictive index in this study was derived by comparing the biochemical state of a cancer cell receptor that is critical to the process of angiogenesis or vascularization of tumors. This PDx Index(TM) of patients with head and neck cancer showed a direct correlation between the drug regimen and patient response. This new technology is applicable to predicting the clinical outcome of most molecular targeted cancer drugs.

Dr. Darren Davis, ApoCell's President and CEO comments, "We have developed the PDx Index(TM) methodology to give drug developers, clinical investigators and oncologists a quantitative tool to predict effectiveness of cancer drug treatment. Recent research has demonstrated that different individuals respond differently to the same cancer drug therapy.
'"/>




Page: 1 2

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
Post Your Comments:
(Date:3/3/2015)... -- Today, the Partnership for Prescription Assistance (PPA), ... companies, unveiled a redesigned website with ... caregivers with faster, easier access to information on ... programs. Since its launch in ... educate and empower patients and caregivers to access ...
(Date:3/3/2015)... -- - CPhI and P-MEC China 2015 ... Shanghai, China - The 15th ... held at Shanghai New International Expo Center, on 24th June, ... Worldwide and was introduced to China in 2001. It has ... companies and global pharmaceutical industry over the past 15 years. ...
(Date:3/3/2015)... 3, 2015  Tru-D SmartUVC will exhibit the ... Perioperative Registered Nurses, Surgical Conference and Expo 2015 ... Patient Safety Awareness Week March 7 through 11. ... clinical practice and professional development. ... http://photos.prnewswire.com/prnh/20150302/178998LOGO   Tru-D SmartUVC,s ...
Breaking Medicine Technology:Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 215th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3
... Jan. 26, 2012  Watson Pharmaceuticals, Inc. (NYSE: ... States Court of Appeals for the Federal Circuit ... for a stay of the preliminary injunction preventing ... Sodium Injection, a generic equivalent to Sanofi-aventis, LOVENOX®.  ...
... Inc. (Nasdaq: CRDC ) today announced that ... Proximal Anastomosis System during on- and off-pump coronary artery ... secure connection, or anastomosis, between a vein graft and ... during CABG procedures and was first shipped to Japan ...
Cached Medicine Technology:Watson Confirms Court Stays Preliminary Injunction 2Watson Confirms Court Stays Preliminary Injunction 3Cardica Achieves Key Milestone With Over 25,000 PAS-Port® Proximal Anastomosis Systems Deployed Worldwide 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 The ... better predict antidepressant treatment outcomes for patients with ... than any of the individual genes that comprise ... investigators from the Mayo Clinic and Assurex Health, ... , The proprietary technology of the GeneSight ...
(Date:3/3/2015)... With a grant of more than ... (GHPC) has been named a national coordinating center by ... Bridging for Health: Improving Community Health Through Innovations in ... improve health and reduce disparities through innovations in collaboration ... work of the center and up to 10 communities ...
(Date:3/3/2015)... 03, 2015 -- vRad ( Virtual Radiologic ), the ... that Arlene Sussman, MD, a highly regarded breast imaging ... to explore how telemedicine best practices allow for the ... women virtually anywhere. Click here to register ... March 4, 2015 at 1:00 pm CT. , Hospitals ...
(Date:3/3/2015)... March 03, 2015 Introducing 3D ... Labs is a recognized leader in Digital Dentistry. ... produces the best dental replicas, leaving no room ... digital scanning, dental professionals are able to significantly ... printers consistently deliver remarkable quality while reducing labor ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 In a ... Morning Edition, science correspondent Shankar Vedantam shared ... Pennsylvania about the drastic decrease in hand-hygiene compliance that occurs ... that the problem could be solved in part by alerts ... hygiene when they enter and exit a patient’s room. ...
Breaking Medicine News(10 mins):Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3
... his last public remarks as,the leader of a large biopharmaceutical ... LLY ), today said that the promise of personalized,medicine ... reward companies for the long-term, expensive research required,to move innovative ... Taurel, who will retire ...
... - Enables Seniors to Easily Compare and Purchase Medicare Plans , ... Options, Including Medicare Supplement Plans, According to Health Plan One Executive ... Health Plan One, L.L.C., a leading online health insurance ... -- for seniors to more quickly compare available Medicare ...
... N.J., Dec. 12 Alfacell Corporation (Nasdaq: ... chief financial officer and corporate secretary, will resign as an ... remain on the board of directors of Alfacell and will ... secretary until at least January 31, 2009. Mr. Kenyon ...
... AOC ), the world,s leading provider of global ... the firm in,January as regional director of Aon Environmental Services ... the unit,s services to,clients in the APAC region. , ... , Finnamore brings over ...
... Dec. 12 The Female Health Company (NYSE ... Administration,s (FDA) Obstetrics and Gynecology Devices Advisory Committee has unanimously ... Condom(R), is approvable with a single condition. , ... that the product is approvable with the condition that the ...
... clear before malaria elimination can be achieved. A supplement ... of articles reviewing the many aspects of the research ... supplement,s reviews charts the progress that has been made ... rather than clinical disease prevention. Elimination requires a different ...
Cached Medicine News:Health News:Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies 2Health News:Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies 3Health News:Health Plan One Launches Enhanced Web Site for Medicare Plans 2Health News:Health Plan One Launches Enhanced Web Site for Medicare Plans 3Health News:Alfacell Announces Management Update 2Health News:Alfacell Announces Management Update 3Health News:Aon Appoints Environmental Veteran to Oversee Risk Management Services for Clients in Far East, Asia and Australia 2Health News:Aon Appoints Environmental Veteran to Oversee Risk Management Services for Clients in Far East, Asia and Australia 3Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5Health News:Malaria Journal supplement evaluates steps toward elimination 2
... M Tests are qualitative enzyme immunoassays (EIA) ... antibodies (IgG or IgM, respectively) in serum. ... should be supplemented with a standardized western ... used to support a clinical diagnosis of ...
The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...
... The ImmunoWELL Cardiolipin Antibody (IgM) ... (EIA) for the quantitative detection ... in serum and is used ... the risk of thrombosis in ...
The miniSPO 2 T has the same advanced DOX digital technology as our multiple parameter vital signs monitors and lets you evaluate oxygen saturation and heart rate in a broad range of patients, from n...
Medicine Products: